: Q4 CONS NET PROFIT 430M RUPEES VS 265M (YOY) || Q4 REVENUE 2.04B RUPEES VS 1.7B (YOY) ADVANCED ENZYME: Q4 EBITDA 633M RUPEES VS 457M (YOY) || Q4 EBITDA MARGIN 31.12% VS 27.33% (YOY) ADVANCED ENZYME: BOARD RECOMMENDS A FINAL DIVIDEND OF ₹1.35 PER EQUITY SHARE